Study | Treatment | Dose normalized parameter | Arithmetic mean ± SD (N) | Geometric mean (N) | Ratio of dose normalized geometric meanb | |||
---|---|---|---|---|---|---|---|---|
N | Ratio PRF-021: Control | Lower 95% CI | Upper 95% CI | |||||
1 | PRF-021 | AUC0-24h/D μg*h/mL/g | 383.2 ± 202.8 (20) | 325 (20) | 20 | 3.63 | 2.57 | 5.14 |
Control | 122.2 ± 93.10 (20) | 89.5 (20) | ||||||
PRF-021 | Cmax/D μg/mL/g | 33.4 ± 20.9 (20) | 34.3 (20) | 20 | 2.68 | 2.09 | 3.44 | |
Control | 7.95 ± 5.68 (20) | 12.8 (20) | ||||||
2 | PRF-021 | AUC0-24h/D μg*h/mL/g | 328.9 ± 195.1 (39a) | 266 (39) | 39 | 5.61 | 3.97 | 7.92 |
Control | 70.70 ± 53.88 (40) | 48.1 (40) | ||||||
PRF-021 | Cmax/D μg/mL/g | 28.2 ± 20.4 (39a) | 36.4 (39a) | 39 | 4.29 | 3.31 | 5.55 | |
Control | 3.88 ± 4.56 (40) | 8.50 (40) |